4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-043975
Chief Executive Officer sold 10,031 shares at $41.23 ($413,578)
- Chief Executive Officer acquired 19,688 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2025-03-20 | Option exercise | +19,688 | 205,116 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2025-03-21 | Sale | −10,031 | $41.23 | $413,578 | 195,085 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2025-03-20 | Option exercise · Restricted Stock Units | −19,688 | 59,062 | D | ||
| Open-market sales · 10,031 sh · avg $41.23 · $413,578 | |||||||
Loading xslF345X05/ownership.xml…